Still Perfecting Radioiodine in Thyroid Cancer, After All These Years
Author(s) -
Lori J. Wirth
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-02437
Subject(s) - thyroid cancer , medicine , thyroid , cancer , nuclear medicine
Dunn et al. report on vemurafenib redifferentiation in BRAFV660E DTC. Tumor biopsies showed pharmacologic reprogramming. Decades after RAI was brought into the clinic, we are still perfecting its use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom